Cargando…

Prediction of Ovarian Hyperstimulation Syndrome in Patients Treated with Corifollitropin alfa or rFSH in a GnRH Antagonist Protocol

STUDY QUESTION: What is the threshold for the prediction of moderate to severe or severe ovarian hyperstimulation syndrome (OHSS) based on the number of growing follicles ≥ 11 mm and/or estradiol (E(2)) levels? SUMMARY ANSWER: The optimal threshold of follicles ≥11 mm on the day of hCG to identify t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Griesinger, Georg, Verweij, Pierre J. M., Gates, Davis, Devroey, Paul, Gordon, Keith, Stegmann, Barbara J., Tarlatzis, Basil C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4780699/ https://www.ncbi.nlm.nih.gov/pubmed/26950065 http://dx.doi.org/10.1371/journal.pone.0149615

Ejemplares similares

Corifollitropin alfa compared to daily rFSH or HP-HMG in GnRH antagonist controlled ovarian stimulation protocol for patients undergoing assisted reproduction
por: Souza, Priscila Morais Galvão, et al.
Publicado: (2017)

The role of corifollitropin alfa in controlled ovarian stimulation for IVF in combination with GnRH antagonist
por: Seyhan, Ayse, et al.
Publicado: (2011)

Predictive factors for ovarian response in a corifollitropin alfa/GnRH antagonist protocol for controlled ovarian stimulation in IVF/ICSI cycles
por: Oehninger, Sergio, et al.
Publicado: (2015)

Corifollitropin alfa or rFSH treatment flexibility options for controlled ovarian stimulation: a post hoc analysis of the Engage trial
por: Leader, Arthur, et al.
Publicado: (2013)

Repeated ovarian stimulation with corifollitropin alfa in patients in a GnRH antagonist protocol: no concern for immunogenicity
por: Norman, Robert J., et al.
Publicado: (2011)

A double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the first seven days of ovarian stimulation using a GnRH antagonist protocol
por: Devroey, P., et al.
Publicado: (2009)

Comparison of GnRH Agonist, GnRH Antagonist, and GnRH Antagonist Mild Protocol of Controlled Ovarian Hyperstimulation in Good Prognosis Patients
por: Stimpfel, Martin, et al.
Publicado: (2015)

Randomized controlled trial comparing embryonic quality in rFSH versus hMG in the IVF protocol with GnRH Antagonist
por: Chapon, Rita de Cassia Borges, et al.
Publicado: (2021)

Corifollitropin stimulation in combination with GnRH-antagonists after estradiol valerate pre-treatment. A pilot study on patientfriendly IVF
por: Decleer, W, et al.
Publicado: (2015)

A new approach for ovarian stimulation in IVF using Corifollitropin Alfa in combination with GnRH analogues to trigger final oocyte maturation. A pilot study
por: Decleer, W., et al.
Publicado: (2014)

Cumulus Cells Gene Expression Profiling in Terms of Oocyte Maturity in Controlled Ovarian Hyperstimulation Using GnRH Agonist or GnRH Antagonist
por: Devjak, Rok, et al.
Publicado: (2012)

GnRH Analogues in the Prevention of Ovarian Hyperstimulation Syndrome
por: Alama, Pilar, et al.
Publicado: (2013)

Cumulative Live Birth Rates Following Stimulation With Corifollitropin Alfa Compared With hp-hMG in a GnRH Antagonist Protocol in Poor Ovarian Responders
por: Errázuriz, Joaquín, et al.
Publicado: (2019)

Evaluation of the safety and efficacy of corifollitropin alfa combined with GnRH agonist triggering in oocyte donation cycles. A prospective longitudinal study
por: Tsakiridis, Ioannis, et al.
Publicado: (2020)

Progestin primed ovarian stimulation using corifollitropin alfa in PCOS women effectively prevents LH surge and reduces injection burden compared to GnRH antagonist protocol
por: Huang, Ting-Chi, et al.
Publicado: (2021)

Stop GnRH-Agonist Combined With Multiple-Dose GnRH-Antagonist Protocol for Patients With “Genuine” Poor Response Undergoing Controlled Ovarian Hyperstimulation for IVF
por: Orvieto, Raoul, et al.
Publicado: (2020)

Comparative economic study of the use of corifollitropin alfa and daily rFSH for controlled ovarian stimulation in older patients: Cost-minimization analysis based on the PURSUE study
por: Barrenetxea, Gorka, et al.
Publicado: (2018)

Clinical Efficacy of Follitropin Alfa in GnRH-Antagonist Protocols: A Prospective Observational Phase IV Study on the Use of Biosimilar Follitropin Alfa r-hFSH in Assisted Reproductive Technology in a Routine Care Setting
por: Griesinger, Georg, et al.
Publicado: (2021)

Severe early ovarian hyperstimulation syndrome following GnRH agonist trigger and freeze-all strategy in GnRH antagonist protocol; case report and literature review
por: Hajizadeh, Nazanin, et al.
Publicado: (2023)

GnRH agonist versus GnRH antagonist in assisted reproduction cycles: oocyte morphology
por: Cota, Ana Marcia M, et al.
Publicado: (2012)

Comparison of long GnRH agonist versus GnRH antagonist protocol in poor responders
por: Şahin, Sadık, et al.
Publicado: (2014)

GnRH Antagonists Produce Differential Modulation of the Signaling Pathways Mediated by GnRH Receptors
por: Sperduti, Samantha, et al.
Publicado: (2019)

Comparison of two different starting dose of rhFSH in GnRH antagonist protocol for patients with normal ovarian reserve
por: Jia, Zhi-cheng, et al.
Publicado: (2023)

A retrospective, matched case-control study of recombinant LH versus hMG supplementation on FSH during controlled ovarian hyperstimulation in the GnRH-antagonist protocol
por: Chen, Ming-Jer, et al.
Publicado: (2022)

GnRH agonist versus GnRH antagonist in in vitro fertilization and embryo transfer (IVF/ET)
por: Depalo, Raffaella, et al.
Publicado: (2012)

The effect of luteinizing hormone changes in GnRH antagonist protocol on the outcome of controlled ovarian hyperstimulation and embryo transfer
por: Zhou, Jing-Shuang, et al.
Publicado: (2023)

GnRH Antagonist IVF Protocol in PCOS
por: Onofriescu, Alina, et al.
Publicado: (2013)

Corrigendum: A retrospective, matched case-control study of recombinant LH versus hMG supplementation on FSH during controlled ovarian hyperstimulation in the GnRH-antagonist protocol
por: Chen, Ming-Jer, et al.
Publicado: (2022)

Impact of add-back FSH on human and mouse prostate following gonadotropin ablation by GnRH antagonist treatment
por: Deiktakis, Eleftherios E, et al.
Publicado: (2022)

Cost-effectiveness analysis of GnRH-agonist long-protocol and GnRH-antagonist protocol for in vitro fertilization
por: Jing, Miaomiao, et al.
Publicado: (2020)

Stop GnRH-agonist/GnRH-antagonist protocol: a different insight on ovarian stimulation for IVF
por: Orvieto, Raoul
Publicado: (2023)

SAT-295 Low Dose rFSH Prior to HCG-rFSH Therapy in Kallmann Syndrome
por: Yoshizawa-Ogasawara, Atsuko, et al.
Publicado: (2019)

A Flexible Multidose GnRH Antagonist versus a Microdose Flare-Up GnRH Agonist Combined with a Flexible Multidose GnRH Antagonist Protocol in Poor Responders to IVF
por: Turgay Çelik, Gayem İnayet, et al.
Publicado: (2015)

Outpatient management of severe early OHSS by administration of GnRH antagonist in the luteal phase: an observational cohort study
por: Lainas, George T, et al.
Publicado: (2012)

Low dose of rFSH [100 IU] in controlled ovarian hyperstimulation response: a pilot study
por: Barbosa, Caio Parente, et al.
Publicado: (2014)

Microdose GnRH Agonist Flare-Up versus Ultrashort GnRH Agonist Combined with Fixed GnRH Antagonist in Poor Responders of Assisted Reproductive Techniques Cycles
por: Eftekhar, Maryam, et al.
Publicado: (2013)

Comparison of hCG triggering versus hCG in combination with a GnRH agonist: a prospective randomized controlled trial
por: Decleer, W., et al.
Publicado: (2014)

Early-cleavage is a reliable predictor for embryo implantation in the GnRH agonist protocols but not in the GnRH antagonist protocols
por: Yang, Wen-Jui, et al.
Publicado: (2009)

A randomized controlled trial of AMH-based individualized FSH dosing in a GnRH antagonist protocol for IVF
por: Friis Petersen, J, et al.
Publicado: (2019)

Recent Development of Non-Peptide GnRH Antagonists
por: Tukun, Feng-Ling, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2ctmj1dkifi9us1hu1ke1l747r